Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain Read more about Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist) Read more about Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma Read more about Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
A Novel, Regulated Gene Therapy (NGN-401) Study for Female Children With Rett Syndrome Read more about A Novel, Regulated Gene Therapy (NGN-401) Study for Female Children With Rett Syndrome
SEAL™IT: Saccular Endovascular Aneurysm Lattice System Interventional Pivotal Trial Read more about SEAL™IT: Saccular Endovascular Aneurysm Lattice System Interventional Pivotal Trial
MicroVention, Inc. Flow Re-Direction Endoluminal Device X (FRED™ X™) Post-Approval Study Read more about MicroVention, Inc. Flow Re-Direction Endoluminal Device X (FRED™ X™) Post-Approval Study
US Pilot Study of the CereVasc® eShunt® System in Normal Pressure Hydrocephalus Read more about US Pilot Study of the CereVasc® eShunt® System in Normal Pressure Hydrocephalus
Post Approval Study - Evaluate the Long-Term Safety and Effectiveness of the WEB Device Read more about Post Approval Study - Evaluate the Long-Term Safety and Effectiveness of the WEB Device
An Open-label Study of XEN1101 in Epilepsy Read more about An Open-label Study of XEN1101 in Epilepsy